Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tomudex versus 5-fluorouracil plus leucovorin in advanced colorectal carcinoma
ISRCTN99195212Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2000
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial in colorectal cancer (CRC) comparing Tomudex with Leucovorin + 5-fluorouracil (2 arms). Started Jan 2000; status: completed.
02
Drugs
raltitrexedfluorouracilfolinic acid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ISRCTN99195212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN99195212.